Gene · 2877
Papers1,817
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 1,817
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Concordant transcriptomics analysis of the lungs and blood after exposure to diesel exhaust: A randomized, controlled human exposure study. | Environ Res | 2026 | 42722095 | PubTator, text mining | PubMed |
| Transcriptional insights into liver toxicity from mixture effects of pesticides and natural toxins: A case study of propyzamide and microcystins. | Toxicology | 2026 | 42710566 | PubTator, text mining | PubMed |
| Phillygenin protects against lipopolysaccharide-induced acute lung injury by acting as a PXR agonist via NF-κB inhibition. | Sci Rep | 2026 | 42686835 | PubTator, text mining | PubMed |
| Selenium Nanoparticles Selectively Target KRAS G13D to Inhibit Colorectal Cancer. | Adv Sci (Weinh) | 2026 | 42610521 | PubTator, text mining | PubMed |
| ZDHHC16-induced GPX2 S-palmitoylation promotes lenvatinib resistance and inhibits lenvatinib-induced immunogenic cell death in hepatocellular carcinoma. | Drug Resist Updat | 2026 | 42497564 | PubTator, text mining | PubMed |
| Hydrolyzed corn starch with maltotetraose for skin defense through NRF2 pathway activation in human keratinocytes. | PLoS One | 2026 | 42361126 | PubTator, text mining | PubMed |
| Regulation of Glutathione Peroxidases (GPxs) in Breast Cancer: From Mechanisms to Targeted Therapeutics. | J Biochem Mol Toxicol | 2026 | 42224423 | PubTator, text mining | PubMed |
| Glutathione peroxidase 2 expression in human tumors: a tissue microarray study on 18,555 tumors. | Front Oncol | 2026 | 42158439 | PubTator, text mining | PubMed |
| CT-based immune radiomic signature for prognosis and prediction of immunotherapy and anticancer drug response in NSCLC. | Front Immunol | 2026 | 42136648 | PubTator, text mining | PubMed |
| USP10 confers lenvatinib resistance in hepatocellular carcinoma by deubiquitinating the GPX2. | Cell Oncol (Dordr) | 2026 | 42133228 | PubTator, text mining | PubMed |
| Dental pulp stem cell-derived exosomes attenuate psoriatic inflammation by restoring epithelial redox homeostasis via a miR-1246/miR-17-3p-GPX2-NF-κB axis. | Stem Cell Res Ther | 2026 | 42106764 | PubTator, text mining | PubMed |
| Multiple disulfide-bonded states confer extensive conformational diversity in fibrinogen. | Protein Sci | 2026 | 41940651 | PubTator, text mining | PubMed |
| GPX2+ tumor cells recruit LGALS1+ B cells via CCL26-CCR3 axis to promote immunosuppression and tumor progression in hepatocellular carcinoma. | Front Immunol | 2026 | 41939890 | PubTator, text mining | PubMed |
| RETRACTION: Elevated Glutathione Peroxidase 2 Expression Promotes Cisplatin Resistance in Lung Adenocarcinoma. | Oxid Med Cell Longev | 2026 | 41915109 | PubTator, text mining | PubMed |
| Computational framework for therapeutic target discovery via perturbation simulation: application to cystic fibrosis airway disease. | Brief Bioinform | 2026 | 41883030 | PubTator, text mining | PubMed |
| p63 in skin homeostasis and disease: molecular mechanisms and therapeutic potentials. | Cell Death Discov | 2026 | 41876478 | PubTator, text mining | PubMed |
| Impact of recalcification on procoagulant collagen-and-thrombin-activated (COAT) platelet generation in platelet-rich plasma samples with low platelet counts. | Res Pract Thromb Haemost | 2026 | 41810334 | PubTator, text mining | PubMed |
| Warfarin-GPRP: Development and Evaluation of a Novel Warfarin-Based Peptide Conjugate for Enhanced Anticoagulant Activity. | ACS Omega | 2026 | 41768631 | PubTator, text mining | PubMed |
| Region-Specific NRF2 Signaling in HIV-Associated Neurocognitive Disorders: A Transcriptomic and Computational Histology Study. | Genes (Basel) | 2026 | 41751579 | PubTator, text mining | PubMed |
| Single-Cell Analysis Reveals Epithelial Heterogeneity and Tumor Microenvironment Characteristics During the Malignant Progression of Colorectal Cancer. | Biomedicines | 2026 | 41751270 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2877/papers